Shethah Morgan

1.9k total citations
37 papers, 1.4k citations indexed

About

Shethah Morgan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Shethah Morgan has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Shethah Morgan's work include Colorectal Cancer Treatments and Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Shethah Morgan is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Shethah Morgan collaborates with scholars based in United Kingdom, United States and China. Shethah Morgan's co-authors include Anthony Nash, Eva M. Lenz, Jonathan Bright, Ian D. Wilson, Craig D. Williams, A. Dyer, Chris Womack, Melanie M. Frigault, Jane Robertson and Juliane M. Jürgensmeier and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cell Metabolism.

In The Last Decade

Shethah Morgan

37 papers receiving 1.4k citations

Peers

Shethah Morgan
Stratigoula Sakellariou Greece
Joon Mee Kim South Korea
Zai‐yuan Ye China
Yan Zhu China
Raffaele Longo Italy
Yongkun Sun China
Norihiko Suzuki Japan
Yasuyuki Kato Japan
Yih‐Huei Uen Taiwan
Chung-Tsen Hsueh United States
Stratigoula Sakellariou Greece
Shethah Morgan
Citations per year, relative to Shethah Morgan Shethah Morgan (= 1×) peers Stratigoula Sakellariou

Countries citing papers authored by Shethah Morgan

Since Specialization
Citations

This map shows the geographic impact of Shethah Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shethah Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shethah Morgan more than expected).

Fields of papers citing papers by Shethah Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shethah Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shethah Morgan. The network helps show where Shethah Morgan may publish in the future.

Co-authorship network of co-authors of Shethah Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Shethah Morgan. A scholar is included among the top collaborators of Shethah Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shethah Morgan. Shethah Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Nikunj, Chad Gwaltney, Afsaneh Barzi, et al.. (2021). Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview study. Quality of Life Research. 31(2). 473–485. 15 indexed citations
2.
Yang, Jin‐Ji, Jian Fang, Yongqian Shu, et al.. (2020). A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancer. Investigational New Drugs. 39(2). 477–487. 43 indexed citations
3.
4.
Gan, Hui, Michael Millward, Hua Ye, et al.. (2019). First-in-Human Phase I Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Antitumor Activity. Clinical Cancer Research. 25(16). 4924–4932. 41 indexed citations
5.
6.
Hamilton, Erika, Manish R. Patel, Anne Armstrong, et al.. (2018). A First-in-Human Study of the New Oral Selective Estrogen Receptor Degrader AZD9496 for ER+/HER2− Advanced Breast Cancer. Clinical Cancer Research. 24(15). 3510–3518. 67 indexed citations
7.
Pommier, Aurélien, Matthew R. Farren, Bhavika Patel, et al.. (2015). Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal Cancer. Cell Metabolism. 23(1). 77–93. 15 indexed citations
8.
Pommier, Aurélien, Robert A. Shaw, Stuart Spencer, et al.. (2014). Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib. British Journal of Cancer. 111(8). 1590–1604. 13 indexed citations
9.
Rana, Sumandeep, et al.. (2014). Designer Phenethylamines Routinely Found in Human Urine: 2-Ethylamino-1-Phenylbutane and 2-Amino-1-Phenylbutane. Journal of Analytical Toxicology. 38(2). 106–109. 7 indexed citations
10.
11.
Jürgensmeier, Juliane M., Hans‐Joachim Schmoll, Jane Robertson, et al.. (2013). Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy. British Journal of Cancer. 108(6). 1316–1323. 50 indexed citations
12.
Smith, John, Laura Brooks, Paulo M. Hoff, et al.. (2013). KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib. European Journal of Cancer. 49(10). 2424–2432. 14 indexed citations
13.
Spencer, Stuart, Aurélien Pommier, Shethah Morgan, et al.. (2013). Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy. British Journal of Cancer. 109(11). 2765–2773. 21 indexed citations
14.
Rajeshkumar, N.V., Aik Choon Tan, Elizabeth De Oliveira, et al.. (2009). Antitumor Effects and Biomarkers of Activity of AZD0530, a Src Inhibitor, in Pancreatic Cancer. Clinical Cancer Research. 15(12). 4138–4146. 75 indexed citations
15.
Gerlag, Daniëlle M., Jasper J. Haringman, Tom Smeets, et al.. (2004). Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. Arthritis & Rheumatism. 50(12). 3783–3791. 124 indexed citations
16.
Lenz, Eva M., Jonathan Bright, Ian D. Wilson, Shethah Morgan, & Anthony Nash. (2003). A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. Journal of Pharmaceutical and Biomedical Analysis. 33(5). 1103–1115. 196 indexed citations
17.
Morgan, Shethah. (2003). Magnetic resonance imaging measurement of knee cartilage volume in a multicentre study. British journal of rheumatology. 43(1). 19–21. 21 indexed citations
18.
Dyer, A., et al.. (2000). The use of zeolites as slow release anthelmintic carriers. Journal of Helminthology. 74(2). 137–141. 7 indexed citations
19.
Devine, Peter L., Geoffrey W. Birrell, Michael N. Marsh, et al.. (1994). Screening and Monitoring Coeliac Disease: Multicentre Trial of a New Serum Antibody Test Kit. Disease Markers. 12(1). 71–80. 4 indexed citations
20.
Ensarı, Arzu, Michael N. Marsh, Duncan E. Loft, Shethah Morgan, & Kieran Moriarty. (1993). Morphometric analysis of intestinal mucosa. V. Quantitative histological and immunocytochemical studies of rectal mucosae in gluten sensitivity.. Gut. 34(9). 1225–1229. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stratigoula Sakellariou Breakdown of academic impact, for papers by Joon Mee Kim Breakdown of academic impact, for papers by Zai‐yuan Ye Breakdown of academic impact, for papers by Yan Zhu Breakdown of academic impact, for papers by Raffaele Longo Breakdown of academic impact, for papers by Yongkun Sun Breakdown of academic impact, for papers by Norihiko Suzuki Breakdown of academic impact, for papers by Yasuyuki Kato Breakdown of academic impact, for papers by Yih‐Huei Uen Breakdown of academic impact, for papers by Chung-Tsen Hsueh
Rankless by CCL
2026